Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies
Abstract Background Cancer treatment is increasingly dependent on biomarkers for prognostication and treatment selection. Potential biomarkers are frequently evaluated in prospective-retrospective studies in which biomarkers are measured retrospectively on archived specimens after completion of pros...
Main Authors: | Wei Zhang, Zhiwei Zhang, Julia Krushkal, Aiyi Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-021-01239-4 |
Similar Items
-
A NEW ESTIMATOR OF MEAN USING DOUBLE SAMPLING
by: Kalyan Rao Vadlamudi, et al.
Published: (2017-12-01) -
Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial
by: Gilbert Peter B., et al.
Published: (2020-07-01) -
On Regression Estimators Using Extreme Ranked Set Samples
by: Hani M. Samawi, et al.
Published: (2004-06-01) -
Three phase stratified sampling with ratio method of estimation
by: Bijoy Kumar Pradhan
Published: (2014-01-01) -
A modified efficient difference-type estimator for population mean under two-phase sampling design
by: A. E. Anieting, et al.
Published: (2020-06-01)